BRKM BOUNCIN GAZELLE //Files Request for Symbol Change with

New Post Public Reply Private Reply Replies (0) Message Board

Apr 29, 2013 at 2:13 PM

BRKM >>BOUNCIN GAZELLE //Files Request for Symbol Change with FINRA

2013-04-29 09:30 ET - News Release

Company Applies for Updated Symbol Reflecting New Corporate Identity

CORONA, Calif. -- (Business Wire)

Extreme Biodiesel (Pink Sheets: BRKM) is pleased to announce that the Company has successfully filed the documents with the Financial Industry Regulatory Authority ("FINRA") to officially recognize the recently completed name change from BookMerge Technologies to Extreme Biodiesel, and request a new trading symbol. Management will notify shareholders when the request has been approved and the new symbol takes effect.

Extreme Green Technologies, Inc. was acquired by BookMerge Technologies in 2010, and has since become the sole focus of the Company. Extreme Green Technologies, Inc. was developed in 2003 with the express purpose of producing, distributing, and creating awareness of user-friendly alternative energy products and sources of power. By entering into the quickly expanding biofuels industry, the Company's primary focus is to produce a user-ready, high quality alternative fuel that is priced competitively with petro-diesel. Because there is an impending need to stop global warming and reduce humankind's carbon footprint, Extreme Green Technologies continuously strives to seek out new technologies and produce feasible eco-friendly fuels in order to make a positive impact on both the environment and our domestic economy.

The Company has recently engaged in negotiations with a couple of existing clients; reputable revenue generating companies in the biofuels industry, in an effort to expand its business model and enhance revenues. Extreme Biodiesel seeks to be an emerging West Coast industry leader through the Company’s aggressive acquisition and growth strategy.

“We appreciate the loyal support of our shareholders as we continue to grow and evolve. It is anticipated that this year will bring many results from the momentum we have built in the process,” stated Joe Spadafore, President and Chief Executive Officer of Extreme Biodiesel.

About Extreme Biodiesel: Extreme Biodiesel is a Company dedicated to the production of ecologically friendly biodiesel energy products. The Company's state-of-the-art solutions are designed to provide a realistic means for dramatically reducing the United States' dependence on foreign oil. Extreme Biodiesel entered the industry in 2003 with the creation of biodiesel processors designed chiefly for individual end-users. Extreme Biodiesel is further expanding its scope by increasing biodiesel production and also creating a Co-Op for both individual members and fleet accounts throughout Southern California.

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

For more information please visit our website at: www.extremebiodiesel.com Contact Joe Spadafore, President, CEO, and Corporate Secretary at: 949-280-1557 or joe@extremebiodiesel.com

Contacts:

Extreme Biodiesel
Joe Spadafore, 949-280-1557
President, CEO, and Corporate Secretary
joe@extremebiodiesel.com

Source: Extreme Biodiesel

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Fibocom LTE Modules Test Drive Satellite Connectivity

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...